Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01237691
Other study ID # SPPN1110F01
Secondary ID
Status Completed
Phase N/A
First received November 1, 2010
Last updated April 6, 2018
Start date November 2010
Est. completion date March 2013

Study information

Verified date April 2018
Source Pepperdine University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group.


Description:

The California HOPE pilot program is being implemented under the authority granted in Penal Code 5058.1. The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group compared with parole-as-usual.


Recruitment information / eligibility

Status Completed
Enrollment 105
Est. completion date March 2013
Est. primary completion date October 2012
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Assigned to the Sacramento Metro IV Parole Unit.

- Released from a term of return-to-custody for a violation for, or involving, the use of drugs.

- Have a maximum controlling discharge date at least one year from the date of release from the return-to-custody term.

Exclusion Criteria:

- History of convictions for crimes that require registration under Penal Code Section 290.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
HOPE supervision
HOPE entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). HOPE includes regular random drug testing.
Parole-as-usual
Parolees are supervised under standard parole supervision practice in California.

Locations

Country Name City State
United States Sacramento Metro IV Parole Unit. Sacramento California

Sponsors (3)

Lead Sponsor Collaborator
Pepperdine University University of California, Irvine, University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Days incarcerated Total number of days incarcerated in jail or prison 24 months
Secondary % positive drug tests Percentage of random and scheduled drug tests that test positive for illicit drugs 24 months
Secondary %Missed Percentage of parole appointments that are missed. 24 months
Secondary Revocation rate Percentage of parolees that are revoked from probation and returned to prison for either a technical violation or on a new charge. 24 months
Secondary New arrests Number of new arrests. 24 months
Secondary Perceptions of risk of detection Parolees perceived risk of detection for drug use 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT02299921 - Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure